Carcinoma of the anal canal

Oncology Reviews

Volumn 3, Issue 1, 2009, Pages 27-40

  Marshall, David T ^a   Thomas Jr , Charles R ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Anal canal cancer; Chemoradiation; HPV; Organ preservation

Indexed keywords

ANTIVIRUS AGENT; CETUXIMAB; CISPLATIN; FLUOROURACIL; MITOMYCIN C; PROTEIN TYROSINE KINASE INHIBITOR; WART VIRUS VACCINE;

ADJUVANT THERAPY; ANUS CARCINOMA; ANUS DISEASE; BLOOD TOXICITY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER STAGING; CHRONIC DIARRHEA; CLINICAL FEATURE; CLINICAL TRIAL; COLOSTOMY; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DIARRHEA; DRUG FATALITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXTERNAL BEAM RADIOTHERAPY; FECES INCONTINENCE; HEMOLYTIC UREMIC SYNDROME; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIP FRACTURE; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; NONHUMAN; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; RADIATION DOSE; RECTOSCOPY; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM HEMORRHAGE; REVIEW; SEXUAL DYSFUNCTION; SKIN DISEASE; THROMBOCYTOPENIA; TOMOTHERAPY; TUMOR BIOPSY; UNITED STATES; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

EID: 67349124185     PISSN: 19705557     EISSN: 19705565     Source Type: Journal    
DOI: 10.1007/s12156-009-0006-7     Document Type: Review

References (82)

1. JA Ajani KA Winter LL Gunderson 2008 Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial JAMA 299 1914 1921
2. ML Welton FE Sharkey MS Kahlenberg 2004 The etiology and epidemiology of anal cancer Surg Oncol Clin N Am 13 263 275
3. C Scarpini V White B Muralidhar 2008 Improved screening for anal neoplasia by immunocytochemical detection of minichromosome maintenance proteins Cancer Epidemiol Biomark Prev 17 2855 2864
4. P Gervaz B Hirschel P Morel 2006 Molecular biology of squamous cell carcinoma of the anus Br J Surg 93 531 538
5. A Jemal R Siegel E Ward 2007 Cancer statistics CA Cancer J Clin 57 43 66
6. A Jemal R Siegel E Ward 2008 Cancer statistics CA Cancer J Clin 58 71 96
7. RD Steenbergen J de Wilde SM Wilting 2005 HPV-mediated transformation of the anogenital tract J Clin Virol 32 Suppl S25 S33
8. H zur Hausen 1977 Human papillomaviruses and their possible role in squamous cell carcinomas Curr Top Microbiol Immunol 78 1 30
9. M Frisch 2002 On the etiology of anal squamous carcinoma Dan Med Bull 49 194 209
10. BA Weaver Q Feng KK Holmes 2004 Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men J Infect Dis 189 677 685
11. DL Rousseau Jr CR Thomas Jr NJ Petrelli MS Kahlenberg 2005 Squamous cell carcinoma of the anal canal Surg Oncol 14 121 132
12. JR Daling MM Madeleine LG Johnson 2004 Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer Cancer 101 270 280
13. JM Palefsky EA Holly JT Efirdc 2005 Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men AIDS 19 1407 1414
14. C Oehler-Jänne F Huguet S Provencher 2008 HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy J Clin Oncol 26 2550 2557
15. TA Longacre CS Kong ML Welton 2008 Diagnostic problems in anal pathology Adv Anat Pathol 15 263 278
16. N Dujovny RM Quiros TJ Saclarides 2004 Anorectal anatomy and embryology Surg Oncol Clin N Am 13 277 293
17. American Joint Committee on Cancer (2002) AJCC cancer staging manual. Springer, New York
18. Abeloff MD et al (2008) Abeloff's clinical oncology. Churchill Livingstone/Elsevier, Philadelphia
19. Rouviere H (1938) Anatomy of the human lymphatic system. A compendium translated from the original Anatomie des Lymphatiques Des L'Homme, and rearranged for the use of students and practicioners, by M.J. Tobias. Edwards Brothers, Ann Arbor
20. ND Nigro VK Vaitkevicius B Considine Jr 1974 Combined therapy for cancer of the anal canal: a preliminary report Dis Colon Rectum 17 354 356
21. WE Longo AM Vernava III TP Wade 1995 Rare anal canal cancers in the US veteran: patterns of disease and results of treatment Am Surg 61 495 500
22. C Paterson L Musselman K Chorneyko 2003 Merkel cell (neuroendocrine) carcinoma of the anal canal: report of a case Dis Colon Rectum 46 676 678
23. BK Ragnarsson-Olding PJ Nilsson LB Olding BR Nilsson 2008 Primary ano-rectal malignant melanomas within a population-based national patient series in Sweden during 40 years Acta Oncol 19 1 7
24. JV Klas DA Rothenberger WD Wong RD Madoff 1999 Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes Cancer 85 1686 1693
25. E Deniaud-Alexandre E Touboul E Tiret 2003 Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal Int J Radiat Oncol Biol Phys 56 1259 1273
26. SE Mitchell WM Mendenhall RA Zlotecki RR Carroll 2001 Squamous cell carcinoma of the anal canal Int J Radiat Oncol Biol Phys 49 1007 1013
27. JH Kim B Sarani BA Orkin 2001 HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients Dis Colon Rectum 44 1496 1502
28. DB Frost PC Richards ED Montague 1984 Epidermoid cancer of the anorectum Cancer 53 1285 1293
29. BM Boman CG Moertel MJ O'Connell 1984 Carcinoma of the anal canal. A clinical and pathologic study of 188 cases Cancer 54 114 125
30. JP Gerard O Chapet F Samiei 2001 Management of inguinal lymph node metastases in patients with carcinoma of the anal canal: experience in a series of 270 patients treated in Lyon and review of the literature Cancer 92 77 84
31. GG Grabenbauer H Kessler KE Matzel 2005 Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients Dis Colon Rectum 48 1742 1751
32. Martellucci J, Naldini G, Colosimo C, Cionini L et al (2008) Accuracy of endoanal ultrasound in the follow-up assessment for squamous cell carcinoma of the anal canal treated with radiochemotherapy. Surg Endosc [Epub ahead of print]
33. M Giovannini VJ Bardou R Barclay 2001 Anal carcinoma: prognostic value of endorectal ultrasound (ERUS). Results of a prospective multicenter study Endoscopy 33 231 236
34. BT Nguyen DL Joon V Khoo 2008 Assessing the impact of FDG-PET in the management of anal cancer Radiother Oncol 87 376 382
35. SE Cotter PW Grigsby BA Siegel 2006 FDG-PET/CT in the evaluation of anal carcinoma Int J Radiat Oncol Biol Phys 65 720 725
36. J Kauh M Koshy C Gunthel 2005 Management of anal cancer in the HIV-positive population Oncology (Williston Park) 19 1634 1638
37. A Rabbani R Zlotecki C Morris W Mendenhall 2008 Tumors of the anal canal: organ preservation with radiotherapy Int J Radiat Oncol Biol Phys 72 S273 S274
38. ND Nigro HG Seydel B Considine 1983 Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal Cancer 51 1826 1829
39. H Kanamori T Shima C Morita T Hata 1957 Studies on antitumor activity of mitomycin J Antibiot (Tokyo) 10 120 127
40. Y Shiraha K Sakai T Teranaka 1958-1959 Clinical trials of mitomycin C, a new antitumor antibiotic; preliminary report of results obtained in 82 consecutive cases in the field of general surgery Antibiot Annu 6 533 540
41. CR Thomas Jr KJ Stelzer JG Douglas 1994 Common emergencies in cancer medicine: infectious and treatment-related syndromes. Part II J Natl Med Assoc 86 839 852
42. B Rosenberg L VanCamp JE Trosko VH Mansour 1969 Platinum compounds: a new class of potent antitumour agents Nature 222 385 386
43. HC Harder B Rosenberg 1970 Inhibitory effects of anti-tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in vitro Int J Cancer 6 207 216
44. UKCCCR Anal Cancer Trial Working Party UK Co-ordinating Committee on Cancer Research 1996 Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, mitomycin Lancet 348 1049 1054
45. H Bartelink F Roelofsen F Eschwege 1997 Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups J Clin Oncol 15 2040 2049
46. M Flam M John TF Pajak 1996 Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study J Clin Oncol 14 2527 2539
47. JP Gerard L Ayzac D Hun 1998 Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients Radiother Oncol 46 249 256
48. A Hung C Crane M Delclos 2003 Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index Cancer 97 1195 1202
49. D Musio G Codacci-Pisanelli 2008 Chemotherapy and radiotherapy for anal canal carcinoma JAMA 300 1410 1411
50. LL Hughes TA Rich L Delclos 1989 Radiotherapy for anal cancer: experience from 1979-1987 Int J Radiat Oncol Biol Phys 17 1153 1160
51. EC Constantinou W Daly CY Fung 1997 Time-dose considerations in the treatment of anal cancer Int J Radiat Oncol Biol Phys 39 651 657
52. M John T Pajak M Flam 1996 Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08 Cancer J Sci Am 2 205 211
53. A Konski M Garcia Jr M John 2008 Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08 Int J Radiat Oncol Biol Phys 72 114 118
54. J Papillon 1974 Radiation therapy in the management of epidermoid carcinoma of the anal region Dis Colon Rectum 17 181 187
55. J Papillon JF Montbarbon JP Gerard 1989 Interstitial curietherapy in the conservative treatment of anal and rectal cancers Int J Radiat Oncol Biol Phys 17 1161 1169
56. M Pocard E Tiret K Nugent 1998 Results of salvage abdominoperineal resection for anal cancer after radiotherapy Dis Colon Rectum 41 1488 1493
57. JD Ellenhorn WE Enker SH Quan 1994 Salvage abdominoperineal resection following combined chemotherapy and radiotherapy for epidermoid carcinoma of the anus Ann Surg Oncol 1 105 110
58. JT Mullen MA Rodriguez-Bigas GJ Chang 2007 Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal Ann Surg Oncol 14 478 483
59. DE Schiller BJ Cummings S Rai 2007 Outcomes of salvage surgery for squamous cell carcinoma of the anal canal Ann Surg Oncol 14 2780 2789
60. Papadopoulos K, Thomas CR (2007) Role of combined modality therapy for anal cancer. Gastrointestinal oncology: evidence and analysis, Informa Healthcare, London, pp 199-210
61. (1992) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 41
62. A Wexler AM Berson SE Goldstone 2008 Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy Dis Colon Rectum 51 73 81
63. A Blazy C Hennequin JM Gornet 2005 Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy Dis Colon Rectum 48 1176 1181
64. S Edelman PA Johnstone 2006 Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities Int J Radiat Oncol Biol Phys 66 206 211
65. R Hoffman ML Welton B Klencke 1999 The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer Int J Radiat Oncol Biol Phys 44 127 131
66. JA Sparano PH Wiernik X Hu 1998 Saquinavir enhances the mucosal toxicity of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma Med Oncol 15 50 57
67. F Pajonk J Himmelsbach K Riess 2002 The human immunodeficiency virus (HIV)-1 protease inhibitor saquinavir inhibits proteasome function and causes apoptosis and radiosensitization in non-HIV-associated human cancer cells Cancer Res 62 5230 5235
68. RF Stadler SG Gregorcyk DM Euhus 2004 Outcome of HIV-infected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy Dis Colon Rectum 47 1305 1309
69. DP Ryan JW Clark 2005 Review: management of anal cancer in the HIV-positive population Oncology (Williston Park) 19 1638 1645
70. SC Remick 2005 Review: management of anal cancer in the HIV-positive population Oncology (Williston Park) 19 1645 1648
71. L Kachnic H Tsai J Willins 2008 Early clinical outcome in patients treated for anal canal cancer using dose-painted intensity modulated radiation therapy Int J Radiat Oncol Biol Phys 72 S260
72. R Myerson M Garofalo I El Naqaet 2008 Elective clinical target volumes for conformal therapy in anorectal cancer: an RTOG consensus panel contouring atlas Int J Radiat Oncol Biol Phys 72 S71
73. C Han Y Chen A Liu 2007 Dosimetric study and in vivo dose verification for conformal avoidance treatment of anal adenocarcinoma using helical tomotherapy Med Dosim 32 33 37
74. JS Welsh M Lock PM Harari 2006 Clinical implementation of adaptive helical tomotherapy: a unique approach to image-guided intensity modulated radiotherapy Technol Cancer Res Treat 5 465 479
75. JA Bonner PM Harari J Giralt 2006 Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med 354 567 578
76. JB Vermorken R Mesia F Rivera 2008 Platinum-based chemotherapy plus cetuximab in head and neck cancer N Engl J Med 359 1116 1127
77. C Le Tourneau LL Siu 2008 Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck Curr Opin Oncol 20 256 263
78. KA Ault 2007 Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials Lancet 369 1861 1868
79. LL Villa RL Costa CA Petta 2006 High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up Br J Cancer 95 1459 1466
80. J Paavonen D Jenkins FX Bosch 2007 Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial Lancet 369 2161 2170
81. Palefsky J, Giuliano A (2008) Efficacy of the quadrivalent HPV vaccine against HPV 6/11/16/18-related genital infection in young men. Nice, France. http://www.eurogin.com/2008/EUROGIN2008-LastMinuteAbstracts.pdf
82. Giuliano A, Palefsky J (2008) The efficacy of quadrivalent HPV (types 6/11/16/18) vaccine in reducing the incidence of HPV-related genital disease in young men. Nice, France. http://www.eurogin.com/2008/EUROGIN2008- LastMinuteAbstracts.pdf